Literature DB >> 1336377

Tyrosine kinase inhibitors block calcium channel currents in vascular smooth muscle cells.

S Wijetunge1, C Aalkjaer, M Schachter, A D Hughes.   

Abstract

Selective inhibitors of tyrosine kinases, tyrphostin 23 and genistein, produced concentration-dependent inhibition of voltage-operated calcium channel currents in vascular smooth muscle cells isolated from rabbit ear artery. The potency of these two structurally dissimilar inhibitors was similar to that reported for their action as inhibitors of tyrosine kinases. Daidzein, an inactive analogue of genistein, had little inhibitory effect on calcium channel currents at concentrations below 300 microM consistent with an action of these agents at a tyrosine kinase. However, tyrphostin 1, a reportedly less active tyrphostin derivative, also inhibited calcium channel currents with a potency similar to tyrphostin 23. These findings suggest that voltage-operated calcium channels in vascular smooth muscle may be modulated by endogenous tyrosine kinase(s) which display different sensitivities to inhibitors compared with the epidermal growth factor (EGF) receptor. Alternatively the possibility of direct blocking actions of these inhibitors at voltage-operated calcium channels cannot be excluded.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1336377     DOI: 10.1016/0006-291x(92)90262-j

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  26 in total

Review 1.  Side-effects of protein kinase inhibitors on ion channels.

Authors:  Youn Kyoung Son; Hongzoo Park; Amy L Firth; Won Sun Park
Journal:  J Biosci       Date:  2013-12       Impact factor: 1.826

2.  Tyrosine kinase involvement in renal arteriolar constrictor responses to angiotensin II.

Authors:  P K Carmines; R W Fallet; Q Che; K Fujiwara
Journal:  Hypertension       Date:  2001-02       Impact factor: 10.190

3.  Effects of protein tyrosine kinase inhibitors on voltage-operated calcium channel currents in vascular smooth muscle cells and pp60(c-src) kinase activity.

Authors:  S Wijetunge; J S Lymn; A D Hughes
Journal:  Br J Pharmacol       Date:  2000-04       Impact factor: 8.739

4.  Differential action of a protein tyrosine kinase inhibitor, genistein, on the positive inotropic effect of endothelin-1 and norepinephrine in canine ventricular myocardium.

Authors:  Li Chu; Jian-Xin Zhang; Ikuo Norota; Masao Endoh
Journal:  Br J Pharmacol       Date:  2005-02       Impact factor: 8.739

5.  Inhibition by genistein of the hyperpolarization-activated cation current in porcine sino-atrial node cells.

Authors:  S Shibata; K Ono; T Iijima
Journal:  Br J Pharmacol       Date:  1999-11       Impact factor: 8.739

6.  Activation of cardiac chloride conductance by the tyrosine kinase inhibitor, genistein.

Authors:  L M Shuba; T Asai; S Pelzer; T F McDonald
Journal:  Br J Pharmacol       Date:  1996-09       Impact factor: 8.739

7.  ATP-Dependent inhibition of Ca2+-activated K+ channels in vascular smooth muscle cells by neuropeptide Y.

Authors:  Z Xiong; D W Cheung
Journal:  Pflugers Arch       Date:  1995-11       Impact factor: 3.657

8.  Tyrosine kinase and phosphatase regulation of slow delayed-rectifier K+ current in guinea-pig ventricular myocytes.

Authors:  Sergey Missan; Paul Linsdell; Terence F McDonald
Journal:  J Physiol       Date:  2006-03-31       Impact factor: 5.182

9.  Increase in tone and intracellular Ca2+ in rabbit isolated ear artery by platelet-derived growth factor.

Authors:  A D Hughes
Journal:  Br J Pharmacol       Date:  1995-01       Impact factor: 8.739

10.  Protein and gene expression of Ca2+ channel isoforms in murine colon: effect of inflammation.

Authors:  Minho Kang; Nemat Morsy; Xiaochun Jin; Florea Lupu; Hamid I Akbarali
Journal:  Pflugers Arch       Date:  2004-12       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.